9 years of historical data (2016–2024) · Healthcare · Medical - Care Facilities
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Ardent Health Partners, LLC trades at 5.9x earnings, 45% below its 5-year average of 10.8x, sitting at the 0th percentile of its historical range. Compared to the Healthcare sector median P/E of 23.7x, the stock trades at a discount of 75%. On a free-cash-flow basis, the stock trades at 10.5x P/FCF, 41% below the 5-year average of 17.8x.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|
| Market Cap | $1.3B | $2.3B | — | — | — | — | — |
| Enterprise Value | $3.1B | $4.0B | — | — | — | — | — |
| P/E Ratio → | 5.94 | 10.81 | — | — | — | — | — |
| P/S Ratio | 0.22 | 0.38 | — | — | — | — | — |
| P/B Ratio | 0.82 | 1.49 | — | — | — | — | — |
| P/FCF | 10.51 | 17.78 | — | — | — | — | — |
| P/OCF | 4.25 | 7.20 | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
Ardent Health Partners, LLC's enterprise value stands at 5.6x EBITDA, 23% below its 5-year average of 7.2x. The Healthcare sector median is 13.8x, placing the stock at a 60% discount on an enterprise-value basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.67 | — | — | — | — | — |
| EV / EBITDA | 5.55 | 7.23 | — | — | — | — | — |
| EV / EBIT | 7.56 | 9.31 | — | — | — | — | — |
| EV / FCF | — | 31.31 | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Ardent Health Partners, LLC earns an operating margin of 6.8%. Operating margins have expanded from 4.2% to 6.8% over the past 3 years, signaling improving operational efficiency. ROE of 16.2% indicates solid capital efficiency. ROIC of 9.7% represents adequate returns on invested capital.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 82.7% | 82.7% | 97.4% | 81.4% | 100.0% | 100.0% | 100.0% |
| Operating Margin | 6.8% | 6.8% | 4.2% | 4.2% | 3.6% | 4.1% | 4.0% |
| Net Profit Margin | 3.5% | 3.5% | 0.9% | 3.7% | -3.4% | -1.2% | 0.7% |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|
| ROE | 16.2% | 16.2% | 4.7% | 21.4% | -19.4% | -6.2% | 3.7% |
| ROA | 4.2% | 4.2% | 1.0% | 5.0% | -5.6% | -2.1% | 1.3% |
| ROIC | 9.7% | 9.7% | 5.7% | 6.6% | 6.3% | 8.4% | 11.7% |
| ROCE | 10.0% | 10.0% | 5.6% | 7.0% | 7.5% | 9.3% | 11.2% |
Solvency and debt-coverage ratios — lower is generally safer
Ardent Health Partners, LLC carries a Debt/EBITDA ratio of 4.1x, which is highly leveraged (33% above the sector average of 3.1x). Net debt stands at $1.7B ($2.3B total debt minus $557M cash). Interest coverage of 6.2x is adequate, though a cyclical earnings downturn could tighten the margin of safety.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.50 | 1.50 | 2.21 | 2.27 | 1.77 | 1.25 | 0.61 |
| Debt / EBITDA | 4.13 | 4.13 | 6.47 | 6.72 | 4.30 | 4.12 | 1.54 |
| Net Debt / Equity | — | 1.13 | 1.81 | 1.84 | 1.69 | 1.16 | 0.37 |
| Net Debt / EBITDA | 3.13 | 3.13 | 5.29 | 5.44 | 4.10 | 3.81 | 0.95 |
| Debt / FCF | — | 13.53 | 23.24 | — | — | — | 40.82 |
| Interest Coverage | 6.19 | 6.19 | 3.51 | 2.65 | 1.38 | 1.72 | 3.15 |
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.94x means Ardent Health Partners, LLC can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has improved from 1.74x to 1.94x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 1.94 | 1.94 | 1.63 | 1.74 | 1.38 | 1.45 | 1.44 |
| Quick Ratio | 1.82 | 1.82 | 1.52 | 1.61 | 1.24 | 1.29 | 1.29 |
| Cash Ratio | 0.59 | 0.59 | 0.44 | 0.56 | 0.10 | 0.14 | 0.28 |
| Asset Turnover | — | 1.20 | 1.06 | 1.06 | 1.52 | 1.26 | 1.94 |
| Inventory Turnover | 8.98 | 8.98 | 1.34 | 8.91 | — | — | — |
| Days Sales Outstanding | — | 45.46 | 53.02 | 43.54 | 46.40 | 55.18 | 45.26 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Ardent Health Partners, LLC does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business. The earnings yield of 16.8% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | 92.5% | — | — | — |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|
| Earnings Yield | 16.8% | 9.3% | — | — | — | — | — |
| FCF Yield | 9.5% | 5.6% | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | — | — | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | — | — | — | — | — |
| Shares Outstanding | — | $133M | $143M | $143M | $141M | $141M | $141M |
Compare ARDT with 8 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| ARDTYou | $1B | 5.9 | 5.6 | 10.5 | 82.7% | 6.8% | 16.2% | 9.7% | 4.1 |
| HCA | $118B | 18.7 | 10.8 | 15.4 | 41.5% | 15.8% | — | 19.9% | 3.2 |
| THC | $21B | 15.5 | 7.2 | 8.3 | 41.4% | 16.5% | 16.1% | 13.5% | 3.0 |
| MPW | $3B | -16.5 | 100.9 | 14.1 | — | — | -4.2% | — | 4.6 |
| ACHC | $2B | -1.9 | 8.0 | — | 17.6% | 11.7% | -41.4% | 5.9% | 4.6 |
| UHT | $605M | 34.3 | 20.7 | 12.3 | — | — | 10.6% | — | — |
| CYH | $485M | 0.9 | 0.5 | 2.3 | 56.7% | 11.9% | — | 21.0% | 0.3 |
| AUNA | $161M | 11.0 | 4.4 | 0.9 | 37.2% | 16.1% | 6.5% | 10.0% | 4.1 |
| UHS | $3M | 8.9 | 1.9 | 0.0 | — | 11.5% | 21.0% | 12.4% | 2.0 |
| Healthcare Median | — | 23.7 | 13.8 | 18.8 | 65.8% | -6.3% | -37.3% | -15.0% | 3.1 |
Peers based on L4 peer group classification. Compare multiple stocks →
Includes 30+ ratios · 6 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how ARDT stacks up against sector leader HCA Healthcare, Inc..
Start ComparisonArdent Health Partners, LLC's current P/E ratio is 5.9x. The historical average is 10.8x.
Ardent Health Partners, LLC's current EV/EBITDA is 5.6x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 7.2x.
Ardent Health Partners, LLC's return on equity (ROE) is 16.2%. The historical average is 3.4%.
Based on historical data, Ardent Health Partners, LLC is trading at a P/E of 5.9x. Compare with industry peers and growth rates for a complete picture.
Ardent Health Partners, LLC has 82.7% gross margin and 6.8% operating margin.
Ardent Health Partners, LLC's Debt/EBITDA ratio is 4.1x, indicating high leverage. A ratio above 4x may signal elevated financial risk.